Lung defense mechanisms (second of two parts).

The New England Journal of Medicine Downloaded from nejm.org at DUKE MEDICAL CENTER LIBRARY on November 19, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved.








Lung defense mechanisms (first of two parts).

Gastrin (second of two parts).

Histamine (second of two parts).

Bronchodilator therapy (second of two parts).

Renal transplantation (second of two parts).

Clinical pharmacokinetics (second of two parts).

Polymyositis and dermatomyositis (second of two parts).

Cellular mechanisms for lipid deposition in atherosclerosis (second of two parts).

Aspects of prostaglandin function in the lung (second of two parts).

Clinical pharmacology of oral antidiabetic agents (second of two parts).

Vasodilator therapy of cardiac failure (second of two parts).

Catecholamines and neurologic diseases (second of two parts).

The pathogenesis of atherosclerosis (second of two parts).

Oxygen-dependent microbial killing by phagocytes (second of two parts).

Drug therapy: antiplatelet therapy (second of two parts).

Oxygen toxicity: augmentation of antioxidant defense mechanisms in rat lung.

T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense.

Regulation of respiration: (second of three parts).

Nerve growth factor (second of three parts).

Chlamydial infections (second of three parts).

Enzyme induction (second of three parts).

Noninvasive cardiac diagnosis (second of three parts).

Abdominal surgery (second of three parts).

Forensic stomatology (second of three parts).

Lung defense mechanisms (second of two parts).

Follow Us

Suggest Documents

Lung defense mechanisms (first of two parts).

Gastrin (second of two parts).

Histamine (second of two parts).

Bronchodilator therapy (second of two parts).

Renal transplantation (second of two parts).

Clinical pharmacokinetics (second of two parts).

Polymyositis and dermatomyositis (second of two parts).

Cellular mechanisms for lipid deposition in atherosclerosis (second of two parts).

Aspects of prostaglandin function in the lung (second of two parts).

Clinical pharmacology of oral antidiabetic agents (second of two parts).

Vasodilator therapy of cardiac failure (second of two parts).

Catecholamines and neurologic diseases (second of two parts).

The pathogenesis of atherosclerosis (second of two parts).

Oxygen-dependent microbial killing by phagocytes (second of two parts).

Drug therapy: antiplatelet therapy (second of two parts).

Oxygen toxicity: augmentation of antioxidant defense mechanisms in rat lung.

T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense.

Regulation of respiration: (second of three parts).

Nerve growth factor (second of three parts).

Chlamydial infections (second of three parts).

Enzyme induction (second of three parts).

Noninvasive cardiac diagnosis (second of three parts).

Abdominal surgery (second of three parts).

Forensic stomatology (second of three parts).

Lung defense mechanisms (second of two parts).

Recommend Documents

Follow Us